OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Editorial Board	196
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	148
Inhaled aerosol viral-vectored vaccines against tuberculosis	98
Transmission patterns of hepatitis E virus	94
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?	83
The enigmatic roles of Anelloviridae and Redondoviridae in humans	71
Mutational escape from cellular immunity in viral hepatitis: variations on a theme	70
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	66
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	60
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	59
Editorial Board	57
Human placental models for studying viral infections	49
Editorial overview: Viral pathogenesis	49
Virus–host protein interactions as footprints of human cytomegalovirus replication	47
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	46
Structural basis for neutralization of enterovirus	45
Editorial Board	44
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	43
Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1	42
Emerging technologies in the study of the virome	41
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	41
Recent progress in development of monoclonal antibodies against human cytomegalovirus	41
New preventive strategies for respiratory syncytial virus infection in children	38
The journey of herpesvirus capsids and genomes to the host cell nucleus	36
Time to ‘Mind the Gap’ in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2	35

A complex immune communication between eicosanoids and pulmonary macrophages	33
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	33
Platelets in the pathogenesis of flavivirus disease	32
Engineering therapeutic phages for enhanced antibacterial efficacy	32
Mitigation of evolved bacterial resistance to phage therapy	30
Perspective on taxonomic classification of uncultivated viruses	29
Editorial Board	29
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	29
Epigenetic control of the Epstein-Barr lifecycle	29
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	29
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	28
Asymmetry in icosahedral viruses	28
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	27
Retasking of canonical antiviral factors into proviral effectors	26
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	25
Tissue-resident memory T cells in protective immunity to influenza virus	25
Human organoid models to study coronavirus infections of the respiratory tract	25
When good turns bad: how viruses exploit innate immunity factors	24
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	24
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	24
Oncogenic Animal Herpesviruses	24
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	23
Modeling zoonotic and vector-borne viruses	23
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	23
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	23
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets	23
Mechanisms of HCV resistance to broadly neutralizing antibodies	22
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	22
Immune responses to human respiratory coronaviruses infection in mouse models	22
Deimmunization of flagellin adjuvant for clinical application	21
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	21
Antigenic evolution of SARS coronavirus 2	21
Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity	21
Advances in human monoclonal antibody therapy for HBV infection	20
Broadly neutralizing antibodies against COVID-19	20
Editorial overview	20
The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?	18
Editorial Board	17
Viral Z-RNA triggers ZBP1-dependent cell death	17
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	17
Early signaling pathways in virus-infected cells	16
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2	16
Editorial Board	16
Editorial overview: Special issue on phage therapy	16
How and why RNA genomes are (partially) ordered in viral capsids	15
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	15
Editorial overview: Viral immunology before COVID-19	15
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	15
Accumulation of host cell genetic errors following high-risk HPV infection	15
The dynamic interactome of microRNAs and the human papillomavirus in head and neck cancers	15

Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response	14
Editorial overview: Virus structure and expression	14
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19	14
Structural insights into hepatitis C virus neutralization	14
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	14
Editorial overview: Special issue on virus structure and expression in current opinion in virology	14
Editorial overview: Engineering elimination of chronic viral hepatitis	14
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
The intestinal virome: lessons from animal models	14
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	13
Koala retrovirus and neoplasia: correlation and underlying mechanisms	13
Lying low-chromatin insulation in persistent DNA virus infection	13
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	13
Editorial Board	13
Broad neutralizing antibody-based strategies to tackle influenza	13
Proteases and variants: context matters for SARS-CoV-2 entry assays	13
Editorial Board	13
Phage therapy for secondary bacterial infections with COVID-19	13
Therapeutic approaches to Epstein–Barr virus cancers	12
European regulatory aspects of phage therapy: magistral phage preparations	12
The role of human lipoproteins for hepatitis C virus persistence	12
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	12
Editorial Board	12
A comparative review of adenovirus A12 and C5 oncogenes	12
Zoonotic disease and virome diversity in bats	12
The long and winding road: human papillomavirus entry and subcellular trafficking	12
Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination	12
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	12
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	12
Virus structure and structure-based antivirals	12
Endocytosis of Bacteriophages	12
Editorial Board	12
Animal models of SARS-CoV-2 transmission	11
Ex vivo culture models to study viral infections of the liver	11
Editorial Board	11
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	11